BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases.

Razieh Amini Shadi Moradi Rezvan Najafi Mehrdokht Mazdeh Amir Taherkhani

Published in: Oxidative medicine and cellular longevity (2024)

The findings propose that ponciretin, danthron, chrysophanol, and N-p-coumaroyltyramine might serve as potential choices for the treatment of AD and PD, laying the groundwork for the creation of innovative BACE1 inhibitors.

Keyphrases

machine learning
combination therapy
big data